Association of Bcl1 polymorphism of the glucocorticoid receptor gene locus with response to glucocorticoids in inflammatory bowel disease [2]

Gut

Volumn 56, Issue 9, 2007, Pages 1319-1321

  De Iudicibus, Sara ^a,b   Stocco, Gabriele ^a,b   Martelossi, Stefano ^b   Drigo, Ilenia ^a,b   Norbedo, Stefania ^b   Lionetti, Paolo ^c   Pozzi, Elena ^c   Barabino, Arrigo ^d   Decorti, Giuliana ^a   Bartoli, Fiora ^b   Ventura, Alessandro ^b  

^a UNIVERSITY OF TRIESTE   (Italy)

^b INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; AZATHIOPRINE; GLUCOCORTICOID RECEPTOR; MOLECULAR MARKER; PREDNISONE; PROTEIN BCL I; UNCLASSIFIED DRUG; GLUCOCORTICOID; GLYCOPROTEIN P;

CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; ENTERITIS; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEPTOR GENE; CHILD; GENETICS; TREATMENT OUTCOME;

CHILD; FEMALE; GLUCOCORTICOIDS; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; P-GLYCOPROTEIN; POLYMORPHISM, GENETIC; RECEPTORS, GLUCOCORTICOID; TREATMENT OUTCOME;

EID: 34548120895     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.116160     Document Type: Letter

References (14)

1. Tung J, Loftus EV Jr, Freese DK, et al. A population-based study of the frequency of corticosteroid resistance and dependence in pediatric patients with Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2006;12:1093-100.
2. Munkholm P, Langholz E, Davidsen M, et al. Frequency of glucocorticoid resistance and dependency in Crohn's disease. Gut 1994;35:360-2.
3. Farrell RJ, Kelleher D. Glucocorticoid resistance in inflammatory bowel disease. J Endocrinol 2003;178:339-46.
4. Farrell RJ, Murphy A, Long A, et al. High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. Gastroenterology 2000;118:279- 88.
5. DeRijk R, de Kloet ER. Corticosteroid receptor genetic polymorphisms and stress responsivity. Endocrine 2005;28:263-70.
6. Cascorbi I, Gerloff T, Johne A, et al. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin Pharmacol Ther 2001;69:169-74.
7. Koper JW, Stolk RP, de Lange P, et al. Lack of association between five polymorphisms in the human glucocorticoid receptor gene and glucocorticoid resistance. Hum Genet 1997;99:663-8.
8. Bachmann AW, Sedgley TL, Jackson RV, et al. Glucocorticoid receptor polymorphisms and post-traumatic stress disorder. Psychoneuroendocrinology 2005;30:297-306.
9. Binder V, Hendriksen C, Kreiner S. Prognosis in Crohn's disease-based on results from a regional patient group from the county of Copenhagen. Gut 1985;26:146-50.
10. Ardizzone S, Maconi G, Russo A, et al. Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut 2006;55:47-53.
11. Hyams J, Markowitz J, Lerer T, et al. The natural history of corticosteroid therapy for ulcerative colitis in children. Clin Gastroenterol Hepatol 2006;4:1118-23.
12. Decorti G, De Iudicibus S, Stocco G, et al. Glucocorticoid receptor polymorphisms in inflammatory bowel disease. Gut 2006;55:1053-4.
13. Panarelli M, Holloway CD, Fraser R, et al. Glucocorticoid receptor polymorphism, skin vasoconstriction, and other metabolic intermediate phenotypes in normal human subjects. J Clin Endocrinol Metab 1998;83:1846-52.
14. Sakaeda T. MDR1 genotype-related pharmacokinetics: fact or fiction? Drug Metab Pharmacokinet 2005;20:391-414.